New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

NSF Granted $256K to Predict Severity of COVID Infections

The goal is to prioritize patients coming into the ER to ensure hospital resources are allocated efficiently.

COVID-19 affects people differently. Sometimes it ravishes the immune system, and attacks the lungs, while other cases are asymptomatic and go unnoticed. A recent Newswire press release announced that a Utah-based biotechnology company called Inherent Biosciences received a grant to study epigenetic biomarkers to predict a patient response to COVID-19 infection. The $255,959 grant comes from the National Science Foundation in an effort to develop on-site clinical tests that screen incoming patients and prioritizes hospital resources based on the predicted infection severity.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub